Smruti Mohanty, MD, MS, Assistant Professor of Medicine, University of Chicago Medical Center, discusses non-alcoholic fatty liver disease, its treatment, risk factors and the fact that 5-10% of patients with this condition will develop cirrhosis.

References and Resources
Dassanayake AS, Kasturiratne A, Rajindrajith S, Kalubowila U, Chakrawarthi S, De Silva AP, Makaya M, Mizoue T, Kato N, Wickremasinghe AR, de Silva HJ Hypertriglyceridemia: Prevalence and risk factors for non-alcoholic fatty liver disease among adults in an urban Sri Lankan population. J Gastroenterol Hepatol. 2009 May 19

Dr. Mohanty has disclosed the following:
Fees for non-CME Services Received Directly from a Commercial Interest or their Agents: Speakers’ bureaus for Bristol-Myers Squibb regarding Hepatitis B
Contracted Research: Bristol-Myers Squibb grant for Hepatitis B

Sponsored by The Doctor’s Channel